Addex Therapeutics Ltd ADR (ADXN)
NASDAQ: ADXNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ADXN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.49M
- EPS (TTM)
- -$7.56
- Dividend yield
- None
- 52-week range
- 2.56 – 11.97
- Day range
- 2.98 – 3.16
- Volume / Avg
- 9.57K / 137.87K
- Beta
- —
- Shares outstanding
- 1.75M
52-week range
ADXN stock today
Addex Therapeutics (ADXN) closed at $3.13 on Oct 7, down 0.32% (-$0.01), versus the S&P 500's 0.22% decline. Trading was light, with 9.57K shares changing hands, about 7% of the average daily volume. Shares are 73.9% below their 52-week high of $11.97 and 22.3% above the 52-week low of $2.56, near the bottom of the past year's range.
Addex Therapeutics has posted a net loss over the last twelve months (EPS of -$7.56), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Addex Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
ADXN news
All ADXN newsAddex Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PULMPulmatrix Inc. | 1.49 | +4.20% | $5.44M | vs ADXN |
| DRMADermata Therapeutics Inc. | 1.12 | -0.89% | $5.55M | vs ADXN |
| BGMSBio Green Med Solution Inc. | 0.85 | -0.67% | $5.63M | vs ADXN |
| XBIOXenetic Biosciences Inc. | 2.21 | +2.55% | $5.18M | vs ADXN |
| LNAILunai Bioworks Inc. | 1.09 | -3.54% | $4.94M | vs ADXN |
| PPCBPropanc Biopharma Inc. | 0.4987 | +1.51% | $4.90M | vs ADXN |
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.98 | -1.98% | $4.87M | vs ADXN |
| GELSGelteq Limited | 0.5601 | -3.41% | $6.00M | vs ADXN |
Indexes, lists and sector
Addex Therapeutics stock FAQ
What is Addex Therapeutics's stock price today?
ADXN last traded at $3.13 as of Oct 7, 4:00 PM EDT, down 0.32% on the day. Prices are delayed at least 15 minutes.
What is the ADXN 52-week high?
The 52-week high for ADXN is $11.97 and the 52-week low is $2.56. The stock is currently 73.9% below its high.